Botulinum Toxins

Cosmetic and Clinical Applications
Herausgegeben von Cohen, Joel L.

• Gebundenes Buch

Produktbeschreibung

The book will explain and demonstrate the use of botulinum toxin in combination with other modalities (combination therapy). This is a growing tool but one that needs a comprehensive understanding of how to use toxins in conjunction with other agents and the use of devices in order to achieve best results. As a result the need for physicians to think critically about their use of botulinum toxin, and to move away from routine approaches has grown ever more important. Consensus approaches to best-practice are altering the way toxins are handled and applied: for example, the recent PRS review panel (of which the Editor of this book was involved) altered recommendations for a nunber of sites.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 400
• Erscheinungstermin: 5. September 2017
• Englisch
• Abmessung: 260mm x 183mm x 26mm
• Gewicht: 950g
• ISBN-13: 9781444338256
• ISBN-10: 1444338250
• Artikelnr.: 37706014

Autorenporträt

Joel L. Cohen MD, Director, AboutSkin Dermatology and DermSurgery (Greenwood Village and Lone Tree, Colorado); Associate Clinical Professor, University of Colorado Department of Dermatology, CO, USA, and; Assistant Clinical Professor, University of California Irvine Department of Dermatology, CA, USA David M. Ozog MD, Chair, Department of Dermatology, C.S. Livingood Chair of Dermatology, and Director of Cosmetic Dermatology, Henry Ford Hospital; Assistant Professor, Wayne State University, Detroit, MI, USA Dennis A. Porto MD, (Video Editor), Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA

Inhaltsangabe

List of Contributors   vii Treatment of the Periocular Area - Crow's Feet, Brow, and Bunny Lines 165 Girish S. Munavalli, MD (MHS, FACMS), Anthony V. Benedetto, DO (FACP, FCPP), Brian S. Biesman, MD (FACS), and Carolee M. Cutler Peck, MD About the Companion Website   xiii         Video Table of Contents   xv       1 History of Botulinum Toxin for Medical and Aesthetic Use 1      Alastair Carruthers, FRCPC and Jean Carruthers, MD (FRCS(C), FRCOphth)           2 Anatomy and Aesthetic Principles   13 Timothy M. Greco, MD (FACS), Che
rie M. Ditre, MD, and David M. Ozog, MD (FAAD, FACMS)    3 Botulinum Toxin: From Molecule to Medicine 37            Conor J. Gallagher, PhD and Alan Ackerman, PhD            4 Myobloc   53 Neil S. Sadick, MD (FACP, FAAD, FAACS, FACPh) and Suveena Manhas-Bhutani, MD       5 Abobotulinumtoxin: Development and Aesthetic Usage 65 Gary D. Monheit, MD     6 IncobotulinumtoxinA (Xeomin®/Bocouture®)   79 Ulrich Kühne, MD (DALM) and Matthias Imhof, MD (DALM)      7  Future Injectable Toxins 97 Michael H. Gold, MD      8 Reconstitution, Dilution, Di
usion, and Migration of Botulinum Toxin  109 Murad Alam, MD (MSCI, MBA), Hayes B. Gladstone, MD, and David M. Ozog, MD (FAAD, FACMS)          9 Patient Selection 121 Ryan M. Greene, MD (PhD, FACS), John P. Arkins, BS, and Steven H. Dayan, MD (FACS) 10 Treatment of the Glabella   133 Neal D. Varughese, MD (MBA) and David J. Goldberg, MD (JD)  11  Treatment of the Forehead 147 Joel L. Cohen, MD (FAAD, FACMS) and Ramin Fathi, MD 12 Treatment of the Periocular Area - Crow's Feet, Brow and Bunny Lines Girish S. Munavalli, MD(MHS, FACMS), Antony V. BEnedetto, DO (FACP, FCPP), Brian S. Biesman, MD (FACS), and Carolee M. Cutler Peck, MD 13 Contouring of the Lower Face and of the Lower Leg and Calf   177 Mee young Park, MD (PhD), Dennis A. Porto, MD, and Ki Young Ahn, MD (PhD)                14  Treatment of the Perioral Area 191 Shawn Allen, MD (FAAD, FACMS), Roberta Sengelmann, MD, and Rachel Simmons, MD (FAAD)                15 Neck Rejuvenation   199 Koenraad De Boulle, MD, Lakhdar Belhaouari, MD, and Julia D. Kreger, MD         16  Correction of Facial Asymmetry 213 Scott Rickert, MD (FACS), Lesley F. Childs, MD, and Andrew Blitzer, MD (DDS, FACS)         17  Complications and Di
usion   221 Matteo C. LoPiccolo, MD, Farhaad R. Riyaz, MD, and David M. Ozog, MD (FAAD, FACMS)             18 Combination Therapy of Botulinum Toxin with other Nonsurgical Procedures 233 Amy Forman Taub, MD and Lauren Fine, MD (FAAD)      19 Peri-Procedure Botulinum Toxin for Skin Cancer Patients and Scars   253 Timothy Corcoran Flynn, MD, Molly C. Powers, MD, and David M. Ozog, MD (FAAD, FACMS)      20 Achieving a Natural Look   263 Doris Hexsel, MD, Camile L. Hexsel, MD (FAAD, FACMS), and Carolina Siega, BSc                21 Special Considerations in Darker Skin   275 Chere
Lucas Anthony, MD and Marta I. Rendon, MD (FAAD, FACP)         22 Axillary Hyperhidrosis   285 Ada Regina Trindade de Almeida, MD, Joel L. Cohen, MD (FAAD, FACMS), and Chinobu Chisaki, MD        23 Primary Focal Palm, Sole, Craniofacial, and Compensatory Hyperhidrosis 299 Dee Anna Glaser, MD and Adam R. Mattox, DO (MS)     24  Topical Botulinum Toxin 317 Richard G. Glogau, MD and Eileen Axibal, MD    25  Exciting New Uses of Botulinum Toxin Type A: Dermatology/Dermatologic Surgery and Beyond  329 Donna Bilu Martin, MD (FAAD) and Stephen Mandy, MD (FAAD)              26 Modulating A
ect and Mood with Botulinum Toxin Injections: Psychosocial Implications of Neuromodulators  345 James L. Griffith, MD (MSci), Kevin C. Smith, MD (FRCPC (DERM)), and Murad Alam, MD (MSCI, MBA)   27  OnabotulinumtoxinA (Botox®) in Dermatology 357 Jason J. Emer, MD, Eileen Axibal, MD, Ellen S. Marmur, MD (FAAD), and Heidi Waldorf, MD          Index 369